Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1799525

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1799525

Global Blood Group Typing Market Size Study & Forecast, by Product, Test Type, Technique, End User and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

The Global Blood Group Typing Market, valued at approximately USD 2.13 billion in 2024, is projected to expand at a promising CAGR of 8.70% between 2025 and 2035, ultimately reaching USD 5.33 billion by the end of the forecast period. Blood group typing, a cornerstone diagnostic procedure in modern healthcare, is pivotal for safe blood transfusions, organ transplants, prenatal testing, and emergency medicine. The process involves the precise identification of blood types through advanced serological and molecular techniques, ensuring compatibility and reducing risks of transfusion reactions. Growing incidences of trauma cases, chronic diseases requiring repeated transfusions, and the increasing prevalence of prenatal testing have amplified the demand for efficient, high-throughput typing methods. Furthermore, rapid technological advancements-ranging from microarray-based platforms to massively parallel sequencing-are streamlining workflows while enhancing accuracy, paving the way for faster diagnostics in both clinical and research settings.

A significant catalyst for market expansion lies in the rising global demand for blood and blood products, propelled by aging populations and the growing complexity of surgical interventions. According to global healthcare statistics, millions of units of blood are transfused annually, and emerging economies are witnessing substantial growth in organized blood banking services. The development of portable, point-of-care blood typing devices is expected to revolutionize field diagnostics, particularly in military, disaster relief, and rural healthcare environments. At the same time, integration of automation and AI-driven interpretation tools is reducing human error, thereby improving reliability and patient safety. Despite these advancements, high operational costs and the need for skilled technicians to interpret complex results remain as challenges. However, ongoing R&D investments in cost-effective consumables and reagent stability are anticipated to mitigate these constraints in the coming decade.

From a geographical perspective, North America currently leads the blood group typing market, supported by a mature healthcare infrastructure, strong presence of diagnostic technology innovators, and a well-regulated blood donation ecosystem. The United States, with its vast network of hospitals, blood banks, and research laboratories, remains a key contributor. Europe follows closely, driven by nationalized healthcare systems, stringent quality regulations for transfusion safety, and continuous technological adoption in countries such as Germany, the UK, and France. Asia Pacific is projected to be the fastest-growing region during the forecast period, fueled by rapidly improving healthcare access, rising surgical volumes, and government-backed initiatives to strengthen blood transfusion services in China, India, and Southeast Asia. Meanwhile, Latin America and the Middle East & Africa are emerging as promising frontiers, as local healthcare systems invest in infrastructure upgrades and forge collaborations with global diagnostic providers.

Major market players included in this report are:

  • Grifols, S.A.
  • Bio-Rad Laboratories, Inc.
  • Immucor, Inc.
  • Quotient Limited
  • Ortho Clinical Diagnostics
  • Beckman Coulter, Inc. (Danaher Corporation)
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Agena Bioscience, Inc.
  • BAG Healthcare GmbH
  • Novacyt Group
  • AXO Science
  • Tulip Diagnostics (P) Ltd.

Global Blood Group Typing Market Report Scope:

  • Historical Data - 2023, 2024
  • Base Year for Estimation - 2024
  • Forecast period - 2025-2035
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Product:

  • Consumables
  • Instruments
  • Services

By Test Type:

  • ABO
  • Antigen
  • Antibody
  • HLA

By Technique:

  • Assay-based
  • PCR
  • Microarray
  • Massively Parallel Sequencing

By End User:

  • Hospital
  • Blood Banks

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2025 to 2035.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Blood Group Typing Market Report Scope & Methodology

  • 1.1. Research Objective
  • 1.2. Research Methodology
    • 1.2.1. Forecast Model
    • 1.2.2. Desk Research
    • 1.2.3. Top Down and Bottom-Up Approach
  • 1.3. Research Attributes
  • 1.4. Scope of the Study
    • 1.4.1. Market Definition
    • 1.4.2. Market Segmentation
  • 1.5. Research Assumption
    • 1.5.1. Inclusion & Exclusion
    • 1.5.2. Limitations
    • 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

  • 2.1. CEO/CXO Standpoint
  • 2.2. Strategic Insights
  • 2.3. ESG Analysis
  • 2.4. Key Findings

Chapter 3. Global Blood Group Typing Market Forces Analysis

  • 3.1. Market Forces Shaping The Global Blood Group Typing Market (2024-2035)
  • 3.2. Drivers
    • 3.2.1. (Increasing demand for safe blood transfusions, organ transplants and prenatal testing)
    • 3.2.2. (Advancements in molecular and high-throughput techniques - microarray & MPS)
  • 3.3. Restraints
    • 3.3.1. (High operational, instrumentation and reagent costs)
    • 3.3.2. (Requirement for skilled technicians and regulatory/standardization complexities)
  • 3.4. Opportunities
    • 3.4.1. (Expansion of point-of-care and portable blood typing solutions)
    • 3.4.2. (Growth potential in emerging markets and integration with AI/automation)

Chapter 4. Global Blood Group Typing Industry Analysis

  • 4.1. Porter's 5 Forces Model
    • 4.1.1. Bargaining Power of Buyer
    • 4.1.2. Bargaining Power of Supplier
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Forecast Model (2024-2035)
  • 4.3. PESTEL Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top Investment Opportunities
  • 4.5. Top Winning Strategies (2025)
  • 4.6. Market Share Analysis (2024-2025)
  • 4.7. Global Pricing Analysis And Trends 2025
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Blood Group Typing Market Size & Forecasts by Product 2025-2035

  • 5.1. Market Overview
  • 5.2. Global Blood Group Typing Market Performance - Potential Analysis (2025)
  • 5.3. Consumables
    • 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.3.2. Market size analysis, by region, 2025-2035
  • 5.4. Instruments
    • 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.4.2. Market size analysis, by region, 2025-2035
  • 5.5. Services
    • 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.5.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Blood Group Typing Market Size & Forecasts by Test Type 2025-2035

  • 6.1. Market Overview
  • 6.2. Global Blood Group Typing Market Performance - Potential Analysis (2025)
  • 6.3. ABO
    • 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.3.2. Market size analysis, by region, 2025-2035
  • 6.4. Antigen
    • 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.4.2. Market size analysis, by region, 2025-2035
  • 6.5. Antibody
    • 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.5.2. Market size analysis, by region, 2025-2035
  • 6.6. HLA
    • 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.6.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Blood Group Typing Market Size & Forecasts by Region 2025-2035

  • 7.1. Blood Group Typing Market, Regional Market Snapshot
  • 7.2. Top Leading & Emerging Countries
  • 7.3. North America Blood Group Typing Market
    • 7.3.1. U.S. Blood Group Typing Market
      • 7.3.1.1. Product breakdown size & forecasts, 2025-2035
      • 7.3.1.2. Test type breakdown size & forecasts, 2025-2035
    • 7.3.2. Canada Blood Group Typing Market
      • 7.3.2.1. Product breakdown size & forecasts, 2025-2035
      • 7.3.2.2. Test type breakdown size & forecasts, 2025-2035
  • 7.4. Europe Blood Group Typing Market
    • 7.4.1. UK Blood Group Typing Market
      • 7.4.1.1. Product breakdown size & forecasts, 2025-2035
      • 7.4.1.2. Test type breakdown size & forecasts, 2025-2035
    • 7.4.2. Germany Blood Group Typing Market
      • 7.4.2.1. Product breakdown size & forecasts, 2025-2035
      • 7.4.2.2. Test type breakdown size & forecasts, 2025-2035
    • 7.4.3. France Blood Group Typing Market
      • 7.4.3.1. Product breakdown size & forecasts, 2025-2035
      • 7.4.3.2. Test type breakdown size & forecasts, 2025-2035
    • 7.4.4. Spain Blood Group Typing Market
      • 7.4.4.1. Product breakdown size & forecasts, 2025-2035
      • 7.4.4.2. Test type breakdown size & forecasts, 2025-2035
    • 7.4.5. Italy Blood Group Typing Market
      • 7.4.5.1. Product breakdown size & forecasts, 2025-2035
      • 7.4.5.2. Test type breakdown size & forecasts, 2025-2035
    • 7.4.6. Rest of Europe Blood Group Typing Market
      • 7.4.6.1. Product breakdown size & forecasts, 2025-2035
      • 7.4.6.2. Test type breakdown size & forecasts, 2025-2035
  • 7.5. Asia Pacific Blood Group Typing Market
    • 7.5.1. China Blood Group Typing Market
      • 7.5.1.1. Product breakdown size & forecasts, 2025-2035
      • 7.5.1.2. Test type breakdown size & forecasts, 2025-2035
    • 7.5.2. India Blood Group Typing Market
      • 7.5.2.1. Product breakdown size & forecasts, 2025-2035
      • 7.5.2.2. Test type breakdown size & forecasts, 2025-2035
    • 7.5.3. Japan Blood Group Typing Market
      • 7.5.3.1. Product breakdown size & forecasts, 2025-2035
      • 7.5.3.2. Test type breakdown size & forecasts, 2025-2035
    • 7.5.4. Australia Blood Group Typing Market
      • 7.5.4.1. Product breakdown size & forecasts, 2025-2035
      • 7.5.4.2. Test type breakdown size & forecasts, 2025-2035
    • 7.5.5. South Korea Blood Group Typing Market
      • 7.5.5.1. Product breakdown size & forecasts, 2025-2035
      • 7.5.5.2. Test type breakdown size & forecasts, 2025-2035
    • 7.5.6. Rest of APAC Blood Group Typing Market
      • 7.5.6.1. Product breakdown size & forecasts, 2025-2035
      • 7.5.6.2. Test type breakdown size & forecasts, 2025-2035
  • 7.6. Latin America Blood Group Typing Market
    • 7.6.1. Brazil Blood Group Typing Market
      • 7.6.1.1. Product breakdown size & forecasts, 2025-2035
      • 7.6.1.2. Test type breakdown size & forecasts, 2025-2035
    • 7.6.2. Mexico Blood Group Typing Market
      • 7.6.2.1. Product breakdown size & forecasts, 2025-2035
      • 7.6.2.2. Test type breakdown size & forecasts, 2025-2035
  • 7.7. Middle East and Africa Blood Group Typing Market
    • 7.7.1. UAE Blood Group Typing Market
      • 7.7.1.1. Product breakdown size & forecasts, 2025-2035
      • 7.7.1.2. Test type breakdown size & forecasts, 2025-2035
    • 7.7.2. Saudi Arabia (KSA) Blood Group Typing Market
      • 7.7.2.1. Product breakdown size & forecasts, 2025-2035
      • 7.7.2.2. Test type breakdown size & forecasts, 2025-2035
    • 7.7.3. South Africa Blood Group Typing Market
      • 7.7.3.1. Product breakdown size & forecasts, 2025-2035
      • 7.7.3.2. Test type breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Grifols, S.A.
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Financial Performance (Subject to Data Availability)
    • 8.2.5. Product/Services Port
    • 8.2.6. Recent Development
    • 8.2.7. Market Strategies
    • 8.2.8. SWOT Analysis
  • 8.3. Bio-Rad Laboratories, Inc.
  • 8.4. Immucor, Inc.
  • 8.5. Quotient Limited
  • 8.6. Ortho Clinical Diagnostics
  • 8.7. Beckman Coulter, Inc. (Danaher Corporation)
  • 8.8. Thermo Fisher Scientific Inc.
  • 8.9. Siemens Healthineers AG
  • 8.10. Abbott Laboratories
  • 8.11. Becton, Dickinson and Company
  • 8.12. Agena Bioscience, Inc.
  • 8.13. BAG Healthcare GmbH
  • 8.14. Novacyt Group
  • 8.15. AXO Science
  • 8.16. Tulip Diagnostics (P) Ltd.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!